Q4 2015 13F Holders as of 12/31/2015
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
59.6M
-
Number of holders
-
20
-
Total 13F shares, excl. options
-
4.43M
-
Shares change
-
+34.6K
-
Total reported value, excl. options
-
$30M
-
Value change
-
+$376K
-
Number of buys
-
3
-
Number of sells
-
-9
-
Price
-
$6.78
Significant Holders of Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) as of Q4 2015
24 filings reported holding ALDX - Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q4 2015.
Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) has 20 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.43M shares
of 59.6M outstanding shares and own 7.43% of the company stock.
Largest 10 shareholders include FMR LLC (1.44M shares), PERCEPTIVE ADVISORS LLC (1.24M shares), DEERFIELD MANAGEMENT CO (691K shares), SPHERA FUNDS MANAGEMENT LTD. (239K shares), BAKER BROS. ADVISORS LP (142K shares), Knoll Capital Management, LP (136K shares), VANGUARD GROUP INC (118K shares), MILLENNIUM MANAGEMENT LLC (110K shares), Weiss Multi-Strategy Advisers LLC (76K shares), and SABBY MANAGEMENT, LLC (68.7K shares).
This table shows the top 20 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.